Open AccessThe short-term effects of estradiol, raloxifene, and a phytoestrogen in women with perimenopausal depression
Author(s) -
Peter J. Schmidt,
Shau-Ming Wei,
Pedro E. Martinez,
Rivka R. Ben Dor,
Gioia M. Guerrieri,
Paula P Palladino,
Veronica Harsh,
Howard J. Li,
Paul Wakim,
Lynnette K. Nieman,
David R. Rubinow
Publication year - 2021
Publication title -
menopause
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.086
H-Index - 103
eISSN - 1530-0374
pISSN - 1072-3714
DOI - 10.1097/gme.0000000000001724
Subject(s) - medicine , placebo , raloxifene , hamilton rating scale for depression , depression (economics) , selective estrogen receptor modulator , beck depression inventory , randomized controlled trial , tibolone , menopause , physical therapy , gynecology , anxiety , psychiatry , breast cancer , estrogen receptor , major depressive disorder , alternative medicine , pathology , cancer , amygdala , economics , macroeconomics
We examined the short-term efficacies of three estrogen-like compounds under placebo-controlled conditions in women with perimenopause-related depression (PMD).